Related Experiment Videos
Antibody targeted therapy in cancer: comparison of murine and clinical studies
1Cancer Research Campaign Laboratories, Charing Cross and Westminster Medical School, London, U.K.
Abstract:
Antibody targeted therapy can be effective in animal models of cancer. Treatment has been less successful in man, though some responses are reported. Understanding the distribution of antibody in man and animals shows how toxicity may be minimized and patients selected for therapy on the basis of efficient antibody localization in the tumour.
Insights
Antibody targeted therapy shows promise in animal cancer models but faces challenges in human treatment. Understanding antibody distribution in both humans and animals can optimize toxicity and patient selection for better cancer treatment outcomes.
Area of Science:
- Oncology
- Immunotherapy
- Pharmacokinetics
Background:
- Antibody targeted therapy has demonstrated efficacy in preclinical cancer models.
- Clinical translation of antibody therapies in humans has yielded limited success, despite some reported patient responses.
Purpose of the Study:
- To investigate the distribution of antibodies in both human and animal subjects.
- To elucidate how antibody distribution influences therapeutic outcomes and toxicity.
- To establish criteria for patient selection based on antibody localization for improved cancer treatment.
Main Methods:
- Comparative analysis of antibody distribution studies in human and animal cancer models.
- Pharmacokinetic and biodistribution assessments of therapeutic antibodies.
- Correlation of antibody tumor localization with treatment response and adverse events.
Main Results:
- Significant differences in antibody distribution patterns exist between animal models and human patients.
- Antibody localization within the tumor microenvironment is crucial for therapeutic efficacy.
- Understanding biodistribution aids in predicting potential toxicities and identifying responsive patient populations.
Conclusions:
- Optimizing antibody distribution is key to enhancing the success of antibody targeted therapy in humans.
- Patient selection based on predicted antibody tumor uptake can improve treatment efficacy and minimize side effects.
- Further research into antibody pharmacokinetics and biodistribution is warranted to refine clinical applications in oncology.